Commissions' recommendation on Anti-Rabies Vaccine accepted
The Ministry of Health and Family Welfare has accepted a major recommendation of the National Human Rights Commission on the use of Anti-Rabies Vaccine (ARV). This was conveyed through a communication from the Ministry to the Commission.
As per one of the recommendations of NHRC there was a need to develop 'Emergency Medicines' as a specialty to improve the emergency medical services in the country. Snake bite, dog bite and bleeding should be included in emergency services and their treatment be provided to all free of cost. The Commission had also recommended that an approval should be given to use of Intradermal Rabies Vaccination, as it would reduce the cost by 1/5th. It was felt that this would help even a single patient who was bitten by dog and hence a large number of people could be provided vaccine.
The Ministry communicated that an approval had been granted to the use of Anti-Rabies Vaccine (ARV) in the country through Intradermal (ID) route. The communication also said that the earlier order of the Directorate General of Health Services (DGHS) regarding number of patients attending these centers for allowing them to use ARV through ID route had been done away with. The earlier order of the DGHS had said that Anti-Rabies Vaccine (ARV) would be provided to those hospitals only, which entertained at least 50 dog-bites per day.
As per one of the recommendations of NHRC there was a need to develop 'Emergency Medicines' as a specialty to improve the emergency medical services in the country. Snake bite, dog bite and bleeding should be included in emergency services and their treatment be provided to all free of cost. The Commission had also recommended that an approval should be given to use of Intradermal Rabies Vaccination, as it would reduce the cost by 1/5th. It was felt that this would help even a single patient who was bitten by dog and hence a large number of people could be provided vaccine.
The Ministry communicated that an approval had been granted to the use of Anti-Rabies Vaccine (ARV) in the country through Intradermal (ID) route. The communication also said that the earlier order of the Directorate General of Health Services (DGHS) regarding number of patients attending these centers for allowing them to use ARV through ID route had been done away with. The earlier order of the DGHS had said that Anti-Rabies Vaccine (ARV) would be provided to those hospitals only, which entertained at least 50 dog-bites per day.